Home › Funds › Royce & Associates › TECH

Royce & Associates position in TECH

BIO-TECHNE CORP · Health Care

Royce & Associates reported holding 789,745 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$55.8M, representing 0.45% of its reported portfolio and ranking #39 among its reported holdings. Royce & Associates has disclosed TECH holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

Latest position (Q2 2026)789.75K sh
Reported value held$55.80M
Portfolio Weight0.45%
First reportedQ3 2021
Last changeAdd
Updated2026-10-05

Last updated: 2026-10-05 · Source: SEC EDGAR Form 13F-HR

How Royce & Associates's TECH position evolved

Royce & Associates first disclosed a stake in TECH in Q3 2021 at 78,909 shares (US$38.2M). The position peaked in Q3 2024 at 845,398 shares, worth US$67.6M. Across 20 filings, Royce & Associates increased the stake 15 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 789,745 shares valued at US$55.8M — an increase of 30,033 shares quarter over quarter.. Notable position changes include a 345% increase in Q4 2022 (shares fell 10% over the following quarter), a 54% increase in Q1 2023 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 78.91K $38.24M New
Q4 2021 76.44K $39.55M Reduce
Q1 2022 79.37K $34.37M Add
Q2 2022 95.86K $33.23M Add
Q3 2022 101.50K $28.82M Add
Q4 2022 452.11K $37.47K Add
Q1 2023 695.20K $51.58K Add
Q2 2023 545.64K $44.54M Reduce
Q3 2023 674.28K $45.90M Add
Q4 2023 683.47K $52.74M Add
Q1 2024 796.56K $56.07M Add
Q2 2024 828.10K $59.33M Add
Q3 2024 845.40K $67.57M Add
Q4 2024 860.75K $62.00M Add
Q1 2025 870.18K $51.02M Add
Q2 2025 870.89K $44.81M Hold
Q3 2025 660.03K $36.72M Reduce
Q4 2025 678.50K $39.90M Add
Q1 2026 759.71K $39.70M Add
Q2 2026 789.75K $55.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Royce & Associates held TECH?

Royce & Associates has disclosed TECH holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

What is Royce & Associates's current position in TECH?

As of Q2 2026, Royce & Associates holds 789.75K shares of TECH (BIO-TECHNE CORP), valued at $55.80M, representing 0.45% of its reported portfolio and ranking #39.

Has Royce & Associates been buying or selling TECH?

In the latest 13F filing (Q2 2026), Royce & Associates increased its position in TECH. The position peaked in Q3 2024 at 845.40K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.